Skip to main content

NEXTHERA Capital: Healthcare Asset Management

A hedge fund survey from Deutsche Bank put out this year found that long short strategies are set to be popular with investors and within it specialist long short managers will lead the way as investors are becoming more comfortable with paying for their specialist knowledge. One such manager is NEXTHERA Capital, which is a healthcare dedicated long/short equity strategy with a focus on therapeutics (large cap pharmaceuticals, generics, specialty pharma and biotechnology).  The New York-based hedge fund was launched in July 2015 with $100m in assets and since inception has seen double digit performance, with assets now totalling $380m. They even...